Intensive radiotherapy of locally advanced bladder cancer.
Over a 10-year period, 82 patients with locally advanced bladder cancer were treated by one of two intensive radiotherapy routines. They received either 320 rads/day for 11 consecutive treatment days; or two sets of 320 rads/day for six consecutive treatment days each, with a three-week rest interposed between sets. Side effects were briefly annoying, but quite tolerable. Good quality palliation was obtained. Uncorrected survival rates for the entire series were 48% at 1 year, 20% at 3 years, and 13% at 5 years.
D000230:Adenocarcinoma / Q000532:radiotherapy*; D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy*; D002295:Carcinoma, Transitional Cell / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D001749:Urinary Bladder Neoplasms / Q000401:mortality / Q000532:radiotherapy*